Clinical Trials Logo
  1. Home
  2. Hyperparathyroidism, Primary
  3. NCT00928408

PRIMARA: A Prospective Descriptive Observational Study to Review Mimpara (Cinacalcet) Use in Patients With Primary Hyperparathyroidism in Clinical Practice

Hyperparathyroidism, Primary Clinical Trial

Official title:
PRIMARA: A Prospective Descriptive Observational Study to Review Mimpara (Cinacalcet) Use in Patients With Primary Hyperparathyroidism in Clinical Practice

Clinical Trial Summary

This is a multicentre, descriptive observational study of adult patients with primary HPT receiving cinacalcet in clinical practice in a number of countries in Europe. Patients will be enrolled within 1 month of initiating cinacalcet treatment, and data will be collected prospectively for up to 1 year from initiation. Data will continue to be collected from patients discontinuing cinacalcet before the end of this period.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00928408
Study type Observational
Source Amgen
Contact
Status Completed
Phase
Start date October 2009
Completion date February 2012
View Details
See also
  Status Clinical Trial Phase
Completed NCT03764007 - 18F-Fluorocholine for the Detection of Parathyroid Adenomas Phase 2/Phase 3
Not yet recruiting NCT05556499 - The Bone-parathyroid Crosstalk in Primary Hyperparathyroidism
Completed NCT00936988 - A Multicenter, Open-label Extension Study to Assess the Long-term Safety and Efficacy of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism Phase 2
Completed NCT00936650 - A Study to Assess the Efficacy and Safety of Twice-Daily Dose Regimens of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism (PHPT) Phase 2
Recruiting NCT04948671 - Primary Hyperparathyroidism and Gut Microbiota
Completed NCT02417389 - Efficacy of Cinacalcet in the Control of Primary Hyperparathyroidism Phase 4
Completed NCT00975221 - Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Patients With Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy Phase 3
Recruiting NCT04895631 - 18F-Fluorocholine Positron Emission Tomography (PET) for the Detection of Parathyroid Adenomas Phase 3
Not yet recruiting NCT04126954 - Study on the Use of Cinacalcet in Phosphocalcic Context.
Recruiting NCT05152927 - Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy N/A
Recruiting NCT06230380 - Autofluorescence in Surgery for Primary Hyperparathyroidism N/A
Completed NCT03091140 - Alterations in Muscle's Functional Characteristics After Parathyroid Surgery for Primary Hyperparathyroidism.
Completed NCT03324893 - FCH PET/MRI Parathyroid Localization N/A
Completed NCT05347082 - Frequency of Hyperparathyroidism in Postmenopausal Osteoporosis and Its Treatment N/A